期刊文献+

联合检测CA125、CEA、CA19-9、CA15-3对胃癌诊断的价值 被引量:1

Analysis of CEA,CA125,CA15-3,CA19-9 detection in diagnosis of gastric cancer
原文传递
导出
摘要 目的探讨CEA、CA125、CA15-3、CA19-9表达对胃癌诊断的价值。方法选取2018年6月-2020年6月,临床96例疑似胃癌患者为对象,检测其CA125、CBA、CA19-9、CA15-3等指标,以病理检测情况分为良性病变组及胃癌组两组,观察其指标水平,病理学检测为诊断胃癌的金标准,分析单独检测指标值的基础上,综合联合检测指标表达结果,探究两者在胃癌诊断中的差异值。结果病理检测表明,96例患者中,42例为胃癌,54例为良性病变,胃癌组的联合检测表达值均高于良性病变组,两组比较差异明显(P<0.05).结论血清CBA、CA125、CA15-3、CA19-9在诊断胃癌中具有重要意义,同时,联合检测对诊断胃癌病情和制定治疗方案、评估预后等具有重要价值。 Objective To explore the value of CEA,CA125,CA15-3,CA19-9 expesion in the dagnosis of gastrice cancer.Methods From June 2018 to June 2020,96 clinical patients with suspected gastic cancer were selected as subjects,and their CA125,CEA,CA19-9,CA15-3 and other indicators were detected.The pathological examinations were divided into two groups:benign lesions and gastric cancer groups.Group,observe its index level,pathology detection is the gold standard for the diagnosis of gastric cancer.Based on the analysis of the individual detection index values,he combined detecin index expression results are combined to explore the dfference between the two in the diagnosis of gastric cancer.Results Pathological examination showed that among 96 patients,42 were gastic cancer patients and 54 were benign lesions.Among them,the expression values of CA125,CEA,CA19--9 and CA15-3 in 42 patients with gastric cancer were.higher than those in the benign lesion group,and there were sgnificant diference between the two groups(P<0.05).Conclusion Serum.CEA,CA125,CA15-3,and CA19-9 are of great sigificance in the diagnosis of gastic cancer.At the same time.ombined detecin is of great value in diagnosing the condition of gastric cancer,formulating treatment plans,and evaluating prognosis.
作者 薛鹏飞 Xue Pengfei(Wuzhi County People's Hospital of Jiaozuo City,Henan province,Jiaozuo 454950)
出处 《首都食品与医药》 2021年第23期129-130,共2页 Capital Food Medicine
关键词 胃癌肿瘤标志物 联合检测 单项检测 指标表达 Gastric cancer tumor markers Joint testing Single test ndicator expression
  • 相关文献

参考文献10

二级参考文献59

  • 1吴健民.影响肿瘤标志物检测的因素[J].中华检验医学杂志,2005,28(4):352-354. 被引量:22
  • 2牛海涛(整理),李涛(整理),王一(整理),孙光(整理).2005年欧洲泌尿外科会议睾丸肿瘤诊断治疗指南[J].中华肿瘤杂志,2006,28(8):637-639. 被引量:16
  • 3Tredan O, Galmarini C M, Patel K, et al. Drug resistance and the solid tumor microenvironment [ J ]. J Natl Cancer Inst, 2007, 99(19) :1441 - 1454. 被引量:1
  • 4Vukovic V, Tannock IF. Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan [ J ]. Br J Cancer, 1997, 75(8) :1167 - 1172. 被引量:1
  • 5Raghunand N, Gillies ILl. pH and chemotherapy [ J ]. Novartis Found Symp ,2001,240 : 199 - 211. 被引量:1
  • 6Raghunand N, He X, Van SR, et al. Enhancement of chemo- therapy by manipulation of tumour pHI J]. Br J Gancer, 1999, 80(7) :1005 - 1011. 被引量:1
  • 7Raghunand N, Gillies R J. pH and drug resistance in tumors [ J] Drug Resist Updat, 2000,3 ( 1 ) :39 - 47. 被引量:1
  • 8Wei J, Liu B, Wang L, et al. Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetran- drine on chemotherapeutic agent-associated genes in human gas- tric cancer cell lines [ J ]. Cancer Chemother Pharmacol, 2007, 60(5) :703 -711. 被引量:1
  • 9Wang G, Lemos J R, Iadecola C. Herbal alkaloid tetrandrine: fron an ion channel blocker to inhibitor of tumor proliferation[ J]. Trends Pharmacol Sci, 2004,25 ( 3 ) : 120 - 123. 被引量:1
  • 10Raghunand N, Altbach MI, Van Sluis R, et al. Plasmalemmal pH-gradlents in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy[ J]. Biochem Pharmacol, 1999, 57 ( 3 ) : 309 -312. 被引量:1

共引文献88

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部